University of South Florida
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, University of South Florida sits in the top decile of US sponsors by registered trial count (#131 of 15,742 sponsors by registered trial count).
University of South Florida: 252 sponsored US clinical trials, 44 recruiting.
University of South Florida sponsors 252 registered US clinical trials on ClinicalTrials.gov, 44 of them currently recruiting, and 171 completed. 32 of these trials are in Phase 3-4 (later-stage) and 40 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obsessive - Compulsive Disorder, with 4 trials.
Top-decile sponsor footprint
University of South Florida ranks in the top decile of sponsors by registered trial count (#131 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
171 of 191 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
252 total, page 2 of 6
Microbiome and Rectal Cancer
NCT04223102
Visceral Manifold Study for the Repair of TAAA
NCT03075748
The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach
NCT01933724
Hydrate Heroes for Improving Brain Function & Mood
NCT07241260
A Prospective, Open-Label Study Evaluating the Effectiveness of Gepants for Acute Treatment of Migraine in the Emergency Department
NCT07667621
The WeACT Program for Family Caregivers of People Living With Dementia
NCT07342569
A Randomized Controlled Efficacy Trial of a Telemedicine-based Virtual Reality Clinic for the Treatment of Phobias
NCT07558824
Impact of a Human Origin Heat Inactivated Probiotic-Lactobacillus Paracasei D3.5 (LpD3.5) as Dietary Supplement on Gut Mucin and Intestinal Permeability in Adults With IBD
NCT07017959
Efgartigimod for Stiff Person Syndrome (ESPS)
NCT06528392
Lipid Mediators & Cancer: Montelukast, SPM, and Almonds
NCT06887673
Home-Based Respiratory Muscle Strength Training Program for Individuals With Post-COVID-19 Persistent Dyspnea
NCT06091280
Timing of Active Void Trials After Urogynecologic Procedures
NCT05885958
Should I Have an Elective Induction?
NCT05838313
Vaginal Estradiol Use in Pessary Care
NCT05458375
Lidocaine for Pessary Check Pain Reduction
NCT05493735
Improving Adherence to Homework During Therapy
NCT05866185
An Integrated Nutrition Intervention to Promote Healthy Eating Habits for Children With ASD
NCT05194345
Epidiolex in Typical Absence Seizures
NCT04899050
A Mobile Health Solution for Homework During CBT
NCT04931199
Optimal Metabolic Health Through Continuous Glucose Monitoring
NCT04920058
Adapting Diet and Action for Everyone (ADAPT+)
NCT04800432
Evaluating Adaptive Dispenser Initiation Protocols for MySafeRx During Post-detox Buprenorphine Treatment- a Pilot Study
NCT04449744
Clostridium Histolyticum Collagenase Injection for Urethral Disease
NCT02948842
Rectal Acetaminophen Use During Oocyte Retrievals to Reduce Post-Operative Opioid Utilization
NCT03732469
ShuntCheck Performance Characteristics in Asymptomatic Pseudotumor Cerebri Patients
NCT04309383
Comparison of Sugammadex and Neostigmine During PACU Stay
NCT04096144
Oral Vancomycin for Secondary Prophylaxis of Clostridium Difficile Infection (CDI)
NCT04000555
Assessment of e-Audiology for Providing Clinical Services and Support
NCT04048460
Use of Videos to Improve Patient Knowledge on Prenatal Genetics
NCT03816423
Evidence-based Assessment of Medication Sensitivity in Acute Hepatic Porphyria
NCT03906214
Shared Medical Appointments for Weight Loss
NCT04866966
Observational Biologic or Prosthetic Mesh
NCT03317665
Using Bluetooth Home Blood Pressure Monitors With Pharmacist Interventions
NCT05606783
Omegaven as Alternative Parenteral Fat Nutrition
NCT03662282
Effects of a Volunteer-based Lunch Program on Feelings of Loneliness in Elders
NCT03552328
The Effect Of An Anesthetic Procedure On Post Operative Pain Management In Carpal Tunnel Release
NCT03729375
Diagnostic Odyssey Survey 2
NCT03678740
Upper Extremity Function in Multiple Sclerosis Patients With Advanced Disability Treated With Ocrevus
NCT03562975
Active Limb Orthosis for Home-Use Stroke Hemiparetic Gait Rehabilitation
NCT03649217
Access to Resources for Patients With PTEN Hamartoma Tumor Syndrome
NCT03680924
Anti-FLEX: Flexed Levering of Gluteal Vessels
NCT03286231
Accelerated Resolution Therapy for Complicated Grief
NCT03484338
A Novel Assay for Predicting Surgical Outcomes in Pelvic Organ Prolapse
NCT03534830
Interventions to Attenuate Cognitive Decline: Keys to Staying Sharp
NCT03528486
Proxy-Reported Symptoms and Quality of Life Survey in Zellweger Spectrum Disorders
NCT03440905
Gentrix™ Versus Biological or Prosthetic Mesh
NCT03034213
Sensation Awareness Focused Training for Spouses
NCT03129204
17OHP-C Dosing Among Obese Pregnant Women
NCT03433040
Brazilian Jiu Jitsu vs. Yoga for Treating Symptoms of PTSD
NCT06497400
Pregnancy in Osteogenesis Imperfecta (OI) Registry
NCT03072303
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 11 |
| Phase 2 | 29 |
| Phase 3 | 18 |
| Phase 4 | 14 |
What is open in the University of South Florida pipeline
44 recruiting of 252 indexed (17% open); 171 completed (68%).
Phase mix: 32 late (III/IV) vs 40 early (I/II) (balanced across stages).
Top condition: Obsessive - Compulsive Disorder (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of South Florida: open-pipeline peers nationwide
Peers matched on 252 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
University of South Florida sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 252 trials (± recruiting share)
- Boston Medical Center · 253 trials · 11% recruiting
- Masonic Cancer Center, University of Minnesota · 249 trials · 14% recruiting
- University of Texas at Austin · 257 trials · 23% recruiting
- Pennington Biomedical Research Center · 258 trials · 13% recruiting
Sponsors near 17% open enrollment (± trial volume)
- VA Office of Research and Development · 17% recruiting · 1,668 trials
- Indiana University · 18% recruiting · 890 trials
- ImmunityBio · 17% recruiting · 46 trials
- Old Dominion University · 17% recruiting · 23 trials
Related
What to do with this University of South Florida page
252 registered trials is a research-attention snapshot, not an endorsement of University of South Florida or any single study.
- 44 of University of South Florida's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obsessive - Compulsive Disorder is the condition University of South Florida studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obsessive - Compulsive Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of South Florida pipeline card: 252 registered trials from official public datasets.Report a data error.